Company record
ENDO USA, Inc.
0 FDA warning letters since 2023 and 1 recall in the last 12 months.
Get an email the day FDA posts anything new about ENDO USA, Inc..
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| May 20 | Class II | ENDO USA, Inc. Drug |
Buprenorphine Hydrochloride, Injection, 0.3mg/mL, 5x1 mL Single Dose Vials, Rx only, Manufactured for: Endo USA, Malvern, PA 19855, NDC 42023-179-05. Crystallization; identified as Buprenorphine free base |